Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Phase I data presented for AXL inhibitor DS-1205c plus osimertinib in EGFR-mutated NSCLC

Feb. 3, 2021

Annamycin shows significant therapeutic benefit in metastatic osteosarcoma animal model

Feb. 3, 2021

WCLC 2021: KRAS drugs may do best in tough subtype

Feb. 2, 2021

Updated results presented from TRIDENT-1 study of repotrectinib

Feb. 2, 2021

Mobocertinib shows clinical benefit in patients with exon 20-mutated NSCLC

Feb. 2, 2021

Sun Pharma Advanced Research describes new camptothecin derivative prodrugs

Feb. 2, 2021

Allinky Biopharma presents GTPase KRas inhibitors

Feb. 1, 2021

New galectin-1/galectin-3 inhibitors identified at Galecto Biotech

Feb. 1, 2021

INCB-001158 plus chemotherapy shows promise for treating advanced biliary tract cancer

Feb. 1, 2021

Medshine Discovery patents multitargeted inhibitors of IRAK-4 and BTK

Feb. 1, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 4, 2026.
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
EQ-504 is AhR agonist for ulcerative colitis, related disorders
BioWorld Science
Activating the aryl hydrocarbon receptor (AhR) in immune cells enhances anti-inflammatory pathways and limits pathogenic immune responses. Equillium Inc. has...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.
Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control
BioWorld
A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...